Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2024-08-15
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$2.1bn
reported value
-9.8% vs Q1 2024
49positions
62.0%in top 10
8 new
13 added
4 reduced
9 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY NAMS | $234.9m10.99% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $222.1m10.39% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $181.5m8.49% | Unchanged |
| HILLEVAX INC COM | $153.5m7.18% | Added +835.6k |
| PHATHOM PHARMACEUTICALS INC PHAT | $104.1m4.87% | Unchanged |
| RHYTHM PHARMACEUTICALS INC RYTM | $97.4m4.55% | Added +181.1k |
| BRIDGEBIO PHARMA INC BBIO | $92.0m4.30% | Added +217.0k |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $81.7m3.82% | Unchanged |
| DISC MEDICINE INC IRON | $79.1m3.70% | Added +969.8k |
| VAXCYTE INC PCVX | $78.5m3.67% | Reduced -100.0k |
| EDGEWISE THERAPEUTICS INC EWTX | $67.2m3.14% | Added +427.5k |
| ANAPTYSBIO INC ANAB | $54.3m2.54% | Added +1.3m |
| VERONA PHARMA PLC VRNA | $47.9m2.24% | Added +300.0k |
| KALVISTA PHARMACEUTICALS INC KALV | $43.4m2.03% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $43.1m2.02% | Reduced -200.0k |
| REVOLUTION MEDICINES INC RVMD | $38.7m1.81% | Unchanged |
| ERASCA INC ERAS | $38.3m1.79% | New |
| AGIOS PHARMACEUTICALS INC AGIO | $37.6m1.76% | Added +348.8k |
| SOLENO THERAPEUTICS INC SLNO | $35.7m1.67% | Unchanged |
| ROCKET PHARMACEUTICALS INC RCKT | $33.6m1.57% | Unchanged |
| SAVARA INC SVRA | $32.9m1.54% | Added +4.2m |
| ORIC PHARMACEUTICALS INC ORIC | $29.3m1.37% | Unchanged |
| CG ONCOLOGY INC CGON | $24.3m1.14% | Unchanged |
| PEPGEN INC PEPG | $24.0m1.12% | Unchanged |
| MERUS N V MRUS | $22.1m1.03% | Reduced -373.4k |
| TREVI THERAPEUTICS INC TRVI | $22.0m1.03% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $21.8m1.02% | Unchanged |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $17.5m0.82% | New |
| AUTOLUS THERAPEUTICS PLC AUTL | $16.1m0.75% | Unchanged |
| CEREVEL THERAPEUTICS HLDNG I CERE | $16.1m0.75% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $15.8m0.74% | New |
| IMMATICS N.V IMTX | $13.4m0.63% | New |
| TYRA BIOSCIENCES INC TYRA | $13.3m0.62% | Unchanged |
| MACROGENICS INC MGNX | $12.8m0.60% | Added +539.0k |
| APPLIED THERAPEUTICS INC APLT | $10.7m0.50% | Added +333.3k |
| PUMA BIOTECHNOLOGY INC PBYI | $10.0m0.47% | Added +246.3k |
| 89BIO INC ETNB | $8.0m0.37% | Unchanged |
| ELEVATION ONCOLOGY INC COM | $8.0m0.37% | New |
| COGENT BIOSCIENCES INC COGT | $7.9m0.37% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $7.6m0.36% | Unchanged |
| ARVINAS INC ARVN | $7.6m0.36% | Unchanged |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $7.3m0.34% | New |
| ALLOGENE THERAPEUTICS INC ALLO | $6.7m0.31% | Unchanged |
| AN2 THERAPEUTICS INC ANTX | $4.5m0.21% | Added +700.0k |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $4.4m0.20% | Unchanged |
| DESIGN THERAPEUTICS INC DSGN | $4.0m0.19% | New |
| IMMUNOCORE HLDGS PLC IMCR | $3.7m0.17% | New |
| METAGENOMI INC MGX | $1.0m0.05% | Reduced -33.3k |
| ACLARIS THERAPEUTICS INC ACRS | $290.8k0.01% | Unchanged |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| ALPINE IMMUNE SCIENCES INC NVLS | $124.1m3.1m shares |
| APELLIS PHARMACEUTICALS INC APLS | $52.0m885.2k shares |
| AEROVATE THERAPEUTICS INC | $35.6m1.2m shares |
| STRUCTURE THERAPEUTICS INC GPCR | $27.0m629.2k shares |
| DECIPHERA PHARMACEUTICALS IN DCPH | $22.9m1.5m shares |
| ADVERUM BIOTECHNOLOGIES INC | $15.1m1.1m shares |
| INTELLIA THERAPEUTICS INC NTLA | $5.6m203.7k shares |
| GRITSTONE BIO INC GRTS | $2.6m1.0m shares |
| BLUEBIRD BIO INC | $2.2m1.7m shares |